Advanced search
Publication Cover
Journal of Medical Economics Volume 20, 2017 - Issue 4
Submit an article Journal homepage
772
Views
3
CrossRef citations to date
0
Altmetric
Oncology

Budget impact of everolimus for the treatment of progressive, well-differentiated, non-functional neuroendocrine tumors of gastrointestinal or lung origin that are advanced or metastatic

Darya B. RoseAnalysis Group, Inc., Menlo Park, CA, USA; Correspondence[email protected]
,
Dave NellesenAnalysis Group, Inc., Menlo Park, CA, USA;
,
Maureen P. NearyNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA
&
Beilei CaiNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Pages 395-404 | Received 18 Oct 2016, Accepted 12 Dec 2016, Published online: 04 Jan 2017

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Bhavik J. Pandya, Hongbo Yang, Cynthia Schmeichel, Cynthia Z. Qi & Manasee V. Shah. (2021) A budget impact analysis of gilteritinib for the treatment of relapsed or refractory FLT3mut+ acute myeloid leukemia in a US health plan. Journal of Medical Economics 24:1, pages 19-28.
Read now

Articles from other publishers (2)

Khadidja Abdallah, Isabelle Huys, Kathleen Claes & Steven Simoens. (2021) Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic Review. Frontiers in Pharmacology 12.
Crossref
Enrique Grande, Ángel Díaz, Carlos López, Javier Munarriz, Juan-José Reina, Ruth Vera, Beatriz Bernárdez, Javier Aller, Jaume Capdevila, Rocio Garcia-Carbonero, Paula Jimenez Fonseca & Marta Trapero-Bertran. (2019) Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review. Therapeutic Advances in Endocrinology and Metabolism 10, pages 204201881982821.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.